Oxybutynin Accord 2.5 mg Tablets

What Is Oxybutynin Accord and What Is It Used For?

Oxybutynin Accord is an anticholinergic and antispasmodic medication containing oxybutynin hydrochloride 2.5 mg per tablet. It is primarily used to treat overactive bladder (OAB) symptoms, including urinary urgency, frequent urination, and urge incontinence, as well as neurogenic bladder dysfunction caused by nervous system damage. It is a generic version manufactured by Accord Healthcare.

Oxybutynin, the active ingredient in Oxybutynin Accord, belongs to the antimuscarinic class of drugs. It works through a dual mechanism: it exerts a direct antispasmodic (relaxing) effect on the smooth muscle of the detrusor muscle in the bladder wall, and it blocks the action of the neurotransmitter acetylcholine at muscarinic receptors on the bladder muscle. This combined effect reduces the pressure inside the bladder, decreases the frequency and intensity of involuntary bladder contractions, and increases the functional capacity of the bladder.

For patients with overactive bladder (OAB), Oxybutynin Accord addresses the core symptoms that significantly impact quality of life. Urinary urgency – the sudden, compelling need to urinate that is difficult to defer – is one of the most bothersome symptoms of OAB. Oxybutynin Accord reduces the strength and frequency of these urges, giving patients more time to reach a bathroom. It also reduces the total number of times a person needs to urinate during the day and night (urinary frequency and nocturia), and helps prevent involuntary leakage of urine (urge incontinence).

In patients with neurogenic bladder dysfunction, the bladder does not function normally due to damage to the nervous system. This may occur as a result of conditions such as spinal cord injury, multiple sclerosis, spina bifida, or other neurological disorders. In these cases, the bladder muscle may contract involuntarily and at inappropriate times, leading to incontinence and potentially dangerous increases in bladder pressure. Oxybutynin Accord helps relax the overactive detrusor muscle, reducing the risk of complications such as vesicoureteral reflux and kidney damage.

In children aged 5 years and older, Oxybutynin Accord may be prescribed for urinary incontinence (daytime wetting), increased urinary frequency, and nocturnal enuresis (bedwetting) when non-pharmacological approaches (such as bladder training, alarm therapy, and fluid management) and other medications have not been sufficiently effective. The European Association of Urology (EAU) and the International Children's Continence Society (ICCS) recommend that oxybutynin be used in children only after a thorough evaluation has ruled out underlying structural or neurological causes.

The 2.5 mg strength plays a particularly important clinical role. It allows physicians to initiate therapy at a lower dose than the standard 5 mg tablet, which reduces the likelihood and severity of anticholinergic side effects during the early phase of treatment. This is especially valuable when prescribing for older adults, people with multiple comorbidities, or individuals known to be sensitive to anticholinergic medication. The scored tablet can be halved if an even smaller starting dose is needed.

What Should You Know Before Taking Oxybutynin Accord?

Before starting Oxybutynin Accord, inform your doctor about all your medical conditions, especially glaucoma, urinary retention, myasthenia gravis, severe gastrointestinal conditions, and cognitive impairment. Oxybutynin Accord has several absolute contraindications and requires careful consideration in many patient groups.

Contraindications

You should not take Oxybutynin Accord if any of the following apply to you:

• Allergy to oxybutynin hydrochloride or any of the other ingredients in the tablet – symptoms of an allergic reaction may include itching, rash, swelling of the face, lips, tongue or throat, or difficulty breathing
• Urinary retention (inability to empty the bladder) – including obstruction caused by conditions such as benign prostatic hyperplasia (enlarged prostate), as oxybutynin could worsen the obstruction and lead to acute urinary retention
• Uncontrolled narrow-angle glaucoma (high fluid pressure in the eye) – anticholinergic drugs can further increase intraocular pressure, potentially causing permanent vision damage
• Myasthenia gravis (severe muscle weakness) – oxybutynin may worsen this autoimmune condition by interfering with neuromuscular transmission
• Gastric retention or severe impairment of gastric emptying – anticholinergics reduce gastrointestinal motility and could worsen this condition
• Severe ulcerative colitis (chronic inflammatory bowel disease) – reduced bowel motility may precipitate or worsen toxic megacolon
• Toxic megacolon (severe dilation and inflammation of the colon) – a life-threatening condition that anticholinergics can aggravate
• Frequent urinary urgency at night caused by heart or kidney disease – in these cases, the underlying condition should be treated rather than the bladder symptoms

Warnings and Precautions

Talk to your doctor or pharmacist before taking Oxybutynin Accord if you have or have had any of the following conditions. Your doctor will assess whether Oxybutynin Accord is appropriate for you and may need to monitor you more closely during treatment:

• High blood pressure (hypertension) – oxybutynin may affect cardiovascular function in some patients
• Heart disease – including arrhythmias, coronary artery disease, or heart failure, as anticholinergics can affect heart rate
• Hyperthyroidism (overactive thyroid gland) – may increase susceptibility to anticholinergic effects
• Benign prostatic hyperplasia (enlarged prostate) not causing complete obstruction – requires monitoring for worsening urinary retention
• Cognitive impairment – difficulties with thinking, memory, comprehension, or perception; anticholinergics may worsen cognitive function, particularly in elderly patients
• Autonomic neuropathy (nerve disease such as in Parkinson's disease) – the body's ability to compensate for anticholinergic effects may be impaired
• Hiatal hernia or gastro-oesophageal reflux disease (GORD) – oxybutynin can reduce oesophageal motility and worsen reflux symptoms
• Liver or kidney disease – oxybutynin is metabolised by the liver; impaired hepatic or renal function may lead to increased drug accumulation
• History of drug or substance misuse – cases of oxybutynin dependency have been reported in patients with a history of substance abuse

Dry mouth is a very common side effect that can increase the risk of dental cavities, gum disease, and oral fungal infections (thrush). It is therefore essential to maintain thorough dental hygiene throughout the entire treatment period, including regular brushing, flossing, and dental check-ups.

Risk of heat exhaustion: Because Oxybutynin Accord reduces sweating, there is an increased risk of heat-related illness (heat exhaustion or heatstroke) when used in hot climates or during vigorous physical activity. Patients should stay well hydrated and avoid prolonged exposure to high temperatures.

Use in Elderly Patients

Oxybutynin Accord should be used with particular caution in elderly patients. Older adults are more susceptible to anticholinergic side effects, especially those affecting cognitive function, including confusion, disorientation, memory impairment, and delirium. The American Geriatrics Society Beers Criteria and the European Association of Urology (EAU) guidelines both highlight the need for careful risk-benefit assessment before prescribing anticholinergics to elderly patients. The 2.5 mg strength is clinically valuable in this age group, as it permits initiation at the lowest effective dose (typically 2.5 mg twice daily) with gradual titration and regular cognitive monitoring.

Use in Children

Oxybutynin Accord is not recommended for children under 5 years of age, as safety and efficacy have not been established in this age group. In children aged 5 years and older, Oxybutynin Accord should be used with caution, as younger patients may be more susceptible to anticholinergic side effects including central nervous system effects. Treatment should be initiated at the lowest effective dose, and children should be monitored regularly for adverse effects including changes in behaviour, mood, or cognitive function.

Pregnancy and Breastfeeding

There is limited clinical data on the use of oxybutynin during pregnancy in humans. Because of this uncertainty, Oxybutynin Accord is not recommended during pregnancy unless your doctor considers it absolutely necessary and the potential benefits outweigh the possible risks to the developing baby. If you are pregnant, think you may be pregnant, or are planning to become pregnant, inform your doctor before taking Oxybutynin Accord.

Oxybutynin passes into breast milk, although the amount transferred to a breastfed infant and its clinical significance are not well characterised. Breastfeeding is generally not recommended during treatment with Oxybutynin Accord unless your doctor advises otherwise after considering the benefits and risks.

Driving and Operating Machinery

Oxybutynin Accord can cause drowsiness, dizziness, and blurred vision, which may impair your ability to drive safely or operate machinery. These effects are more likely at the start of treatment, after dose increases, or when combined with alcohol or other sedating medications. If you experience any of these symptoms, you should not drive, operate machinery, or perform activities requiring alertness until the symptoms have fully resolved. You are responsible for assessing whether you are fit to perform these activities while taking this medication.

Alcohol

Alcohol can increase the drowsiness caused by Oxybutynin Accord. If you consume alcoholic beverages while taking this medication, the sedative effects may be more pronounced. It is advisable to limit or avoid alcohol consumption during treatment, particularly until you know how Oxybutynin Accord affects you individually.

Important Information About Excipients

Oxybutynin Accord tablets contain lactose. If you have been told by your doctor that you have an intolerance to certain sugars, contact your doctor before taking this medicine.

How Does Oxybutynin Accord Interact with Other Drugs?

Oxybutynin Accord can interact with a wide range of medications, particularly other anticholinergic drugs, cholinesterase inhibitors used for Alzheimer's disease, antifungal agents, macrolide antibiotics, and drugs that affect gastrointestinal motility. Always tell your doctor about all medications you take, including over-the-counter products and herbal supplements.

Because oxybutynin has anticholinergic properties, its effects can be additive or synergistic with other drugs that also have anticholinergic activity. Conversely, drugs that increase cholinergic activity (such as cholinesterase inhibitors) may have their effectiveness reduced by concurrent use of oxybutynin. Oxybutynin is metabolised primarily by the CYP3A4 enzyme in the liver, meaning that drugs which inhibit or induce this enzyme can alter oxybutynin blood levels.

Major Interactions

Moderate Interactions

Urinary tract infections that develop during treatment with Oxybutynin Accord should be treated with appropriate antibiotics. Your doctor will select an antibiotic that does not significantly interact with oxybutynin. Herbal products, including St John's wort (a known CYP3A4 inducer), may affect oxybutynin blood levels and should be discussed with your doctor or pharmacist.

What Is the Correct Dosage of Oxybutynin Accord?

The usual starting dose for adults is 2.5 mg two to three times daily, which may be gradually increased up to a maximum of 20 mg per day. The 2.5 mg tablets are particularly well suited to careful titration in elderly patients, children, and anyone at higher risk of anticholinergic side effects. Always follow your doctor's dosing instructions.

Always take Oxybutynin Accord exactly as your doctor or pharmacist has instructed you. Do not change your dose without consulting your doctor first. Oxybutynin Accord tablets can be taken before meals and should be swallowed whole with half a glass of water. The scored tablet can be divided for dose adjustment but should not be chewed.

Adults

Elderly Patients

Children (5 Years and Older)

The usual starting dose for children aged 5 and older is 2.5 mg twice daily. Your child's doctor will adjust the dose based on the child's weight, age, and response to treatment, up to a weight-based maximum of 0.3–0.4 mg/kg per day. Oxybutynin Accord is not recommended for children under 5 years of age.

Patients with Kidney or Liver Impairment

In patients with moderate to severe kidney or liver impairment, the starting dose should not exceed 2.5 mg twice daily, and the dose should be titrated cautiously. Oxybutynin is metabolised extensively by the liver, and reduced liver function can lead to higher blood levels and increased side effects. The 2.5 mg strength is well suited to this cautious approach.

Missed Dose

If you forget to take a dose, take it as soon as you remember, unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for the one you missed. If you frequently forget doses, consider setting reminders or aligning your doses with regular daily activities such as meals.

Overdose

What Are the Side Effects of Oxybutynin Accord?

Like all medicines, Oxybutynin Accord can cause side effects, although not everyone experiences them. The most common side effects are anticholinergic in nature and include dry mouth, constipation, blurred vision, dizziness, headache, drowsiness, nausea, and dry skin. Most side effects are dose-dependent and may improve with dose reduction - one reason the 2.5 mg strength is valuable.

The side effects of Oxybutynin Accord are largely related to its anticholinergic mechanism of action. By blocking muscarinic acetylcholine receptors throughout the body (not just in the bladder), oxybutynin can affect multiple organ systems, including the eyes, mouth, gastrointestinal tract, skin, heart, and central nervous system. Understanding these side effects helps you and your doctor make informed decisions about treatment and manage any problems that arise.

If any side effects become severe, or if you notice effects not listed above, contact your doctor or pharmacist promptly. Reporting suspected adverse reactions is important for ongoing monitoring of the medicine's benefit-risk balance. Patients can report adverse reactions directly through national reporting systems, such as the MHRA Yellow Card scheme (UK), the FDA MedWatch program (US), or the EudraVigilance system (EU).

How Should You Store Oxybutynin Accord?

Store Oxybutynin Accord at a temperature below 30°C, in the original packaging, and keep it out of reach and sight of children. Do not use the medication after the expiry date printed on the package.

Proper storage is essential to maintain the effectiveness and safety of your medication. Keep Oxybutynin Accord tablets in their original blister packaging to protect them from moisture and light. Store at room temperature, not exceeding 30°C. Do not store the tablets in the bathroom or other humid environments, as moisture can degrade the active ingredient.

Check the expiry date on the carton and blister pack before use. The expiry date refers to the last day of the stated month. Do not use Oxybutynin Accord after this date, as the medication may no longer be effective or safe.

Do not dispose of unused or expired medicines via household waste or by flushing them down the drain. Return any unwanted medication to your local pharmacy for safe disposal. This helps protect the environment from pharmaceutical contamination, in line with international pharmaceutical waste guidance from the WHO.

What Does Oxybutynin Accord Contain?

Each Oxybutynin Accord tablet contains 2.5 mg of oxybutynin hydrochloride as the active substance. The tablets also contain inactive ingredients including anhydrous lactose, microcrystalline cellulose, and calcium stearate.

Active Substance

The active ingredient is oxybutynin hydrochloride. Each tablet contains 2.5 mg of oxybutynin hydrochloride, equivalent to approximately 2.25 mg of oxybutynin base.

Inactive Ingredients (Excipients)

The other ingredients are:

• Anhydrous lactose – a sugar-based filler (important for patients with lactose intolerance)
• Microcrystalline cellulose – provides bulk and binding properties to the tablet
• Calcium stearate – acts as a lubricant during the tablet manufacturing process

Appearance and Packaging

Oxybutynin Accord 2.5 mg tablets are white, round, and convex, with a score line on one side that allows the tablet to be divided into equal halves for precise dose adjustment. The tablets are supplied in blister packs. Pack sizes commonly include 30, 60, and 100 tablets, although not all pack sizes may be marketed in every country.

Marketing Authorisation Holder and Manufacturer

Oxybutynin Accord is manufactured and marketed by Accord Healthcare, a global pharmaceutical company supplying generic medicines in over 90 countries. As a generic medicine, Oxybutynin Accord has been shown to be bioequivalent to the original reference brand of oxybutynin, meaning it provides the same therapeutic effect at a typically lower cost.